Compare NDMO & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NDMO | IRMD |
|---|---|---|
| Founded | 2019 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 622.4M | 910.4M |
| IPO Year | N/A | 2014 |
| Metric | NDMO | IRMD |
|---|---|---|
| Price | $10.19 | $96.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $72.00 |
| AVG Volume (30 Days) | ★ 218.6K | 74.4K |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | ★ 6.75% | 0.71% |
| EPS Growth | N/A | ★ 13.00 |
| EPS | N/A | ★ 1.65 |
| Revenue | N/A | ★ $80,511,268.00 |
| Revenue This Year | N/A | $15.17 |
| Revenue Next Year | N/A | $10.15 |
| P/E Ratio | ★ N/A | $58.33 |
| Revenue Growth | N/A | ★ 12.91 |
| 52 Week Low | $8.99 | $47.48 |
| 52 Week High | $11.24 | $98.44 |
| Indicator | NDMO | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 32.95 | 75.36 |
| Support Level | $10.22 | $94.94 |
| Resistance Level | $10.66 | $98.44 |
| Average True Range (ATR) | 0.16 | 2.15 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 14.81 | 80.50 |
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.